Antara Capital LP Inventiva S.A. Transaction History

Antara Capital LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$12.55 - $19.0 $3.26 Million - $4.94 Million	-259,857 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$11.35 - $14.5 $1.16 Million - $1.48 Million	-102,143 Reduced 28.22%	259,857 $3.77 Million
Q3 2020 Nov 16, 2020	BUY	$9.87 - $13.42 $3.57 Million - $4.86 Million	362,000 New	362,000 $4.27 Million

4.85M

Ticker IVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,134,200
Market Cap $99M
Description
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company als...

Get notified when there are updates to the investment portfolio of Antara Capital LP, based on Form 13F filings with the SEC.

Stay updated on Antara Capital LP with notifications on news.